Forecast

There is no analyst data available for this company.

News Go to news feed

Editas Medicine plans offering of common stock and pre-funded warrants

Editas Medicine announced the launch of a public, syndicated offering of common shares or pre-funded warrants, along with accompanying warrants. Cantor and Wells Fargo Securities are acting as joint bookrunners; the offering will be conducted using an effective S-3 registration and is subject to customary market conditions. The company has a market capitalization of about $270 million; the stock rose 78% last year to $2.76. On the balance sheet, cash exceeds debt, but the company is consuming significant cash. » More on de.investing.com